Taurine for Longevity: Does the 2023 Science Study Hold Up?

Few longevity supplements have had a bigger single moment than taurine. In June 2023, a paper in Science reported that taurine — a cheap, ubiquitous amino acid you already eat and make — declines with age, and that giving it back extended lifespan in mice and improved health markers in middle-aged monkeys. The coverage was breathless: a longevity molecule hiding in your energy drink. Two years later, a follow-up in the same journal pulled the rug on the study's central claim. This page walks through both halves honestly — what the famous study actually showed, why the rebuttal matters, and where taurine really sits once you separate mouse data from human proof. For the wider map of what's earned its place versus what's hype, start with our pillar on longevity medicine: what's proven vs hyped.

What taurine is

Taurine is a sulfur-containing amino acid — though, unusually, it isn't built into proteins. Your body synthesizes it (mainly in the liver) and you also get it from diet: it's concentrated in meat, fish, and shellfish, which is why vegans and vegetarians tend to have lower intake. It's also the headline ingredient in energy drinks, typically dosed around 1,000 mg per can. Taurine has well-established physiological roles — in bile-acid conjugation, the retina, heart muscle, and as a regulator of cell volume and calcium handling — long before anyone called it a longevity molecule. That everyday-nutrient status matters for the honesty of what follows: taurine is not an exotic drug, and its safety profile at moderate doses is reasonably well characterized.

The 2023 Science study: what it actually claimed

The paper that started the hype was Singh and colleagues, "Taurine deficiency as a driver of aging," published in Science in June 2023¹. It was a genuinely ambitious, multi-species package, and it made three linked claims. First, that circulating taurine concentrations decline with age across mice, monkeys, and humans. Second, that restoring taurine in mice extended median lifespan (the headline figure was on the order of 10–12%) and improved multiple healthspan measures — muscle, bone, metabolic, and immune markers. Third, that taurine supplementation in middle-aged rhesus monkeys improved several health markers over six months, and that in a human cohort, lower taurine tracked with worse cardiometabolic health.

Taken at face value, that's an unusually complete story for a supplement: a molecule that falls with age, a causal lifespan benefit when you replace it in mammals, primate healthspan data, and a human correlation. It's why the study landed so hard. But the load-bearing assumption underneath all of it is the first claim — that taurine declines with age — and that's exactly the part that didn't survive scrutiny.

The 2025 Science follow-up: the core premise didn't hold

In June 2025, a group led by Fernandez and colleagues at the National Institute on Aging published a direct challenge in Science, asking plainly: "Is taurine an aging biomarker?"². Using large longitudinal datasets — humans followed over time, plus rhesus monkeys and mice — they found that blood taurine concentrations did not consistently decline with age. In several datasets taurine was flat or even rose with age, and within individuals the variability swamped any age trend. Their conclusion was blunt: taurine doesn't behave like a reliable aging biomarker, which undercuts the premise that age-related taurine "deficiency" is something to correct in the first place.

This is the crux. The 2023 paper's emotional logic was "you're losing taurine as you age, so put it back." If taurine doesn't actually fall with age in people, that rationale collapses, and the human relevance of the mouse lifespan result becomes much weaker. The 2025 work doesn't prove taurine is useless — it doesn't refute the mouse lifespan extension, which is a separate experiment — but it removes the bridge the 2023 story used to walk from mice to humans. Two high-profile Science papers now disagree about the most basic factual claim in this field, and that disagreement is the single most important thing to understand about taurine and aging.

The animal evidence: real, but it's still mouse data

Strip away the human-decline claim and you're left with the mouse lifespan experiment, which stands on its own: in the 2023 work, taurine supplementation did extend median lifespan and improve healthspan markers in mice¹. That's a real finding worth taking seriously as a reason to keep studying taurine. But it carries the caveat that haunts this entire site: mouse lifespan extensions translate to humans far less often than headlines imply, and a single lab's lifespan result — however careful — is a starting point, not a verdict. Loss of proteostasis, mitochondrial dysfunction, and stem-cell exhaustion are catalogued among the formal hallmarks of aging³, and taurine plausibly touches several; but "plausibly touches a hallmark in mice" is a hypothesis about humans, not a result in them.

What taurine actually does in humans

Here's the irony: taurine has a decent human evidence base — just not for longevity. Where the data are strongest is in narrow, near-term areas.

On exercise, a meta-analysis by Waldron and colleagues found that oral taurine produced a small but measurable improvement in endurance performance⁴, and a sports-nutrition review catalogues plausible mechanisms (calcium handling, antioxidant effects) while noting the effects are modest and dose- and protocol-dependent⁵. A separate meta-analysis of endurance supplements in hot environments likewise placed taurine among ingredients with small ergogenic signals⁶. Crucially, the International Society of Sports Nutrition's position stand on energy drinks concluded that taurine's independent contribution to energy-drink effects is unclear — caffeine does most of the work⁷.

On metabolic health, a 2024 systematic review and meta-analysis of randomized trials found taurine supplementation modestly reduced risk markers for metabolic syndrome⁸, and a randomized, double-blind, placebo-controlled trial in people with type 2 diabetes reported improvements in some glycemic and lipid measures⁹. These are real, controlled human results — but they're surrogate markers (glucose, lipids, blood pressure proxies) in specific populations, not demonstrations that taurine slows aging or extends life.

Zero human longevity trials

It needs saying plainly, because the marketing never does: there is no randomized controlled trial showing taurine extends human lifespan or healthspan, and there isn't one underway that could answer that question soon. The lifespan data are from mice¹. The human data are either an association (now contested) between taurine levels and health¹² or surrogate-marker trials in exercise and metabolic populations⁴⁸⁹. None of that adds up to "proven to make people age slower." This is the same mechanism-versus-outcome gap we apply across the field — see our best longevity supplements, rated by evidence roundup for how consistently it recurs, and our longevity biomarker panels breakdown for how easily a biomarker gets sold as a benefit.

Safety: the reassuring part

If taurine's efficacy story is weak, its safety story is genuinely reasonable, which is part of why people take it anyway. Taurine is consumed daily in food and in energy drinks at roughly 1,000 mg/can, and the doses used in human metabolic and exercise trials (commonly 1–6 g/day) have been well tolerated in those studies⁸⁹. It is sold as a dietary supplement, not an FDA-approved drug for any condition — so it carries no approved indication and no required efficacy proof, and long-term safety at high chronic doses in healthy people specifically for anti-aging hasn't been formally studied. The honest framing is the one this site uses constantly: taurine's safety at studied doses looks acceptable, while its efficacy for longevity in humans is unproven. Those are different claims, and supplement marketing routinely blurs them.

The grade

The bottom line

Taurine is the cleanest recent example of how fast a longevity story can move and how easily a single striking paper outruns its evidence. The 2023 Science study was real and ambitious, and its mouse lifespan result still stands. But its bridge to humans — the claim that taurine declines with age — was directly challenged by a 2025 Science follow-up that found no reliable age-related decline in people or primates. Strip that bridge away and what's left is solid mouse data, a contested human correlation, and genuinely useful but narrow human evidence for exercise and metabolic markers — none of it showing taurine slows human aging. If you take taurine, take it for what it's actually supported to do, at sensible doses, knowing the safety looks reasonable and the longevity payoff in humans is unproven. For where supplements like this fit alongside programs with real clinical oversight, see our graded best longevity clinics hub, and compare taurine's case to the better-mechanism, still-unproven neighbor spermidine for longevity.